| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $89.1M | — |
| Cost of Revenue | $0 | — |
| R&D Expense | $19.6M | -3.4% |
| SG&A Expense | $71.7M | +7525.0% |
| Operating Income | -$3.1M | +95.4% |
| Pre-tax Income | $8.3M | +115.2% |
| Income Tax | $288K | — |
| Net Income | $8.0M | +114.7% |
| EPS (Basic) | $0.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.8M | -28.4% |
| Short-term Investments | $263.2M | +67.2% |
| Accounts Receivable | $8.2M | — |
| Inventory | $5.2M | — |
| Current Assets | $334.3M | +44.3% |
| Total Assets | $351.2M | +50.6% |
| Current Liabilities | $23.4M | +880.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.5M | +122.9% |
| Capital Expenditures | $563K | +221.7% |
| Investing Cash Flow | -$106.1M | -21.7% |
| Financing Cash Flow | $72.4M | +949.4% |
| Free Cash Flow | $13.0M | +121.8% |
| EPS (Diluted) | $0.08 | +114.0% |
| Total Liabilities |
| $94.4M |
| +3786.1% |
| Stockholders' Equity | $256.8M | +11.3% |